Drug prices almost always fall after a manufacturer’s patent expires and generics hit the market. But with its blockbuster cholesterol-fighting drug Lipitor going off-patent this week, drug maker ...

(Reuters) - Indian generic drugmaker Ranbaxy Laboratories Ltd said on Friday it will resume production of its version of Pfizer's cholesterol fighter Lipitor for sale in the United States after ...

Statins are considered safe and effective, but they may not be right for everyone to lower cholesterol.

LOS ANGELES (CBSLA.com) — Several doses of a generic version of Lipitor have been recalled because some batches might contain small glass particles. Indian drug maker Ranbaxy, which manufactures the ...

Current medical news and unique business news for anyone who cares about the healthcare industry. The war over Lipitor: Indian generics maker Ranbaxy was expected to be the first generic manufacturer ...

Pfizer Inc. and India’s Ranbaxy Laboratories Ltd. agreed to keep copies of the cholesterol pill Lipitor off the U.S. market an extra 20 months, protecting $12 billion in sales for Pfizer. Under the ...

TRENTON, N.J. (AP) – Ranbaxy Pharmaceuticals Inc. has recalled dozens of lots of its generic version of cholesterol drug Lipitor because some may contain tiny glass particles, the latest in a string ...

India's largest maker of generic drugs won approval Wednesday to sell a generic version of cholesterol blockbuster Lipitor. The world's top-selling drug ever lost U.S. patent protection earlier in the ...

Amgen on Monday launched direct-to-consumer U.S. sales of its cholesterol medication Repatha at a discounted cash price, ...

TRENTON, N.J. -- Lipitor, the best-selling drug in the history of pharmaceuticals, is the blockbuster that almost wasn't. When it was in development, the cholesterol-lowering medicine was viewed as ...

NEW JERSEY (KTLA) — A generic form of the cholesterol lowering drug Lipitor has been recalled after some batches were found to contain pieces of glass. Indian ...